Eradication Of Generic Drug Policy Division Bodes Poorly For Access, Affordability

By Gabrielle Wanneh / April 9, 2025 at 4:48 PM

The elimination of an FDA division once tasked with overseeing clearances, guidance, policies and other processes affecting the regulation of generic drugs could impede access to affordable generics, Hyman, Phelps & McNamara director Kurt Karst wrote in an FDA Law Blog post Wednesday (April 9) as FDA faces mass layoffs.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.